NCT04134715View on ClinicalTrials.gov

A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

January 9, 2020

Study Completion Date

January 9, 2020

Conditions
Healthy
Interventions
DRUG

PF-06826647

100 mg tablet

DRUG

Oral Contraceptive (OC)

OC in the form of 1 PORTIA (30 µg EE and 150 µg LN) or equivalent tablet

Trial Locations (2)

33126

Quotient Sciences-Miami, Miami

33134

Quotient Sciences Screening Office, Coral Gables

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04134715 - A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants | Biotech Hunter | Biotech Hunter